Basel Medical Group Ltd Ordinary Shares (BMGL) vs CollPlant Biotechnologies Ltd. (CLGN)

A side-by-side comparison of Basel Medical Group Ltd Ordinary Shares and CollPlant Biotechnologies Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BMGL vs CLGN

growth of $100 · dividends reinvested · last 2y
BMGL -94.1% (-75.6%/yr)CLGN -89.5% (-67.7%/yr)CLGN compounded faster over this window
050100Start $1002026$6$10
BMGL CLGN

BMGL vs CLGN: by the numbers

  • •BMGL is the larger company ($5M vs $4M market cap).
  • •Both run net losses; BMGL's is the smaller (-106.78% vs -3934.91% net margin).

Metrics side by side

Valuation

MetricBMGLCLGN
P/S ratioN/A13.90
P/B ratio1.111.50

Profitability

MetricBMGLCLGN
Gross margin77.68%26.32%
Operating margin-19.28%-484.31%
Net margin-106.78%-3934.91%
ROE-248.66%-424.89%
ROIC-35.07%-221.32%

Growth (annualized)

MetricBMGLCLGN
Revenue CAGR (5Y)N/A-56.28%
Total return CAGR (5Y)N/A-53.69%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.